AU2003302109A1 - Prodrug esters of ceftriaxone - Google Patents
Prodrug esters of ceftriaxoneInfo
- Publication number
- AU2003302109A1 AU2003302109A1 AU2003302109A AU2003302109A AU2003302109A1 AU 2003302109 A1 AU2003302109 A1 AU 2003302109A1 AU 2003302109 A AU2003302109 A AU 2003302109A AU 2003302109 A AU2003302109 A AU 2003302109A AU 2003302109 A1 AU2003302109 A1 AU 2003302109A1
- Authority
- AU
- Australia
- Prior art keywords
- ceftriaxone
- prodrug esters
- prodrug
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1175/DEL/2002 | 2002-11-21 | ||
IN1175DE2002 | 2002-11-21 | ||
PCT/IB2003/005327 WO2004046153A1 (fr) | 2002-11-21 | 2003-11-21 | Esters de promedicament de ceftriaxone |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003302109A1 true AU2003302109A1 (en) | 2004-06-15 |
Family
ID=32321381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003302109A Abandoned AU2003302109A1 (en) | 2002-11-21 | 2003-11-21 | Prodrug esters of ceftriaxone |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003302109A1 (fr) |
WO (1) | WO2004046153A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
KR20120087878A (ko) * | 2009-08-10 | 2012-08-07 | 비에이치아이 리미티드 파트너쉽 | 1,3-프로판디설포닉 애시드의 수송을 위한 방법, 화합물 및 조성물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3580263D1 (de) * | 1984-12-28 | 1990-11-29 | Merck & Co Inc | 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles arzneimittel. |
EP0791597B1 (fr) * | 1996-02-21 | 2000-07-12 | Lupin Laboratories Limited | Procédé pour la préparation de céphalosporines et d'intermédiaires |
IT1286494B1 (it) * | 1996-11-19 | 1998-07-15 | Hichem Pharma S P A | Procedimento per la preparazione di derivati cefalosporanici |
WO2000063214A1 (fr) * | 1999-04-15 | 2000-10-26 | Biochemie Gesellschaft M B H | Production de bêta-lactame |
-
2003
- 2003-11-21 AU AU2003302109A patent/AU2003302109A1/en not_active Abandoned
- 2003-11-21 WO PCT/IB2003/005327 patent/WO2004046153A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004046153A1 (fr) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003226373A1 (en) | 5-alkyl-7-alkylcarbonate-isoflavone ester as isoflavone prodrug | |
AU2003202924A1 (en) | Variation of neural-stimulation parameters | |
AU2003234718A1 (en) | Instrument introducer | |
AU2003202259A1 (en) | Lipid compositions, production thereof and of esters | |
AU2003277903A1 (en) | Novel stabilized cinnamic ester sunscreen compositions | |
AU2003287509A1 (en) | Methods of manipulating small amounts of solids | |
AU2003256895A1 (en) | Polytrimethylene ether esters | |
AU2003267638A1 (en) | Endoscope | |
AU2003255310A1 (en) | Silicas | |
AU2003245800A1 (en) | Flavourant compounds | |
AU2003222083A1 (en) | Acid and ester compounds and methods of using the same | |
AU2003206803A1 (en) | Production of alkenones | |
AU2003230395A1 (en) | Micro-support structures | |
AU2003225891A1 (en) | 6"-amino-6"-deoxygalactosylceramides | |
AU2003224051A1 (en) | Watersoluble prodrugs of propofol | |
AU2003248957A1 (en) | Feruloyl esterase and uses thereof | |
AU2003215150A1 (en) | Therapeutic compounds | |
AU2003288237A1 (en) | Artificial esterases | |
AU2003209453A1 (en) | Transposon | |
AU2003302109A1 (en) | Prodrug esters of ceftriaxone | |
AU2003262152A1 (en) | Endoscope | |
AU2003290763A1 (en) | Modulation of jumonji expression | |
AU2003228883A1 (en) | Neopentylglycol bis (diarylphosphate) esters | |
AU2003258716A1 (en) | Tocopheryl ester | |
AU2003266271A1 (en) | Regulation of human esterase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |